Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-16T04:26:34.926Z Has data issue: false hasContentIssue false
  • English
  • Français

Economic Evaluation of Medical Technologies

Published online by Cambridge University Press:  10 March 2009

John Hutton
John Hutton
Affiliation:
Senior Research Fellow Centre for Health EconomicsUniversity of York
Get access Rights & Permissions [Opens in a new window]

Extract

Economic techniques have been used for several years to evaluate health care expenditures, and there is reasonable agreement amongst economists as to the appropriate methodology. Comprehensive reviews of techniques and applications can be found in Drummond (3,4), Culyer and Horisberger (2) and a report from the Office of Technology Assessment (7). More recently Williams (13) has addressed the problems of evaluating a developing technology and Wagner (10) the specific problems of diagnostic technologies.

Type
Technology Assessment: Policy, Clinical, and Methodological Issues
Information
International Journal of Technology Assessment in Health Care , Volume 2 , Issue 1 , January 1986 , pp. 43 - 52
Copyright
Copyright © Cambridge University Press 1986

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Culyer, A. J., Ed. Health Indicators. Oxford: Martin Robertson, 1983.Google Scholar
2.Culyer, A. J., & Horisberger, B., Eds. Economic and Medical Evaluation of Health Care Technologies. Berlin: Springer-Verlag, 1983.CrossRefGoogle Scholar
3.Drummond, M. F.Principles of Economic Appraisal in Health Care. Oxford: Oxford University Press, 1981.Google Scholar
4.Drummond, M. F.Studies in Economic Appraisal in Health Care. Oxford: Oxford University Press, 1981.Google Scholar
5.Drummond, M. F., & Stoddart, G. L.Economic Analysis and Clinical Trials. Controlled Clinical Trials, 1984, 5, 115–128.CrossRefGoogle ScholarPubMed
6.Guyatt, G., & Drummond, M. F.Guidelines for the Economic Assessment of Medical Technologies: The Case of NMR. International Journal of Technology Assessment in Health Care, 1985, forthcoming.CrossRefGoogle Scholar
7.Office of Technology Assessment, The Implications ofCEA of Medical Technology, Methodological Issues and Literature Review, Washington D.C.: Congress of the United States, Government Printing Office, 1980.Google Scholar
8.Pedersen, K. M. Economic Evaluation of Dialysis. In Culyer, A. J. and Horisberger, B., Eds. Economic and Medical Evaluation of Health Care Technologies. Oxford: Oxford University Press, 1981.Google Scholar
9.Rosenthal, G. Anticipating the Costs and Benefits of New Technology: A Typology for Policy. In Altman, S. H. and Blendon, R., Eds., Medical Technology. Hyattsville, Md.: United States Department of Health, Education, and Welfare, 1979.Google Scholar
10.Wagner, J. L.The Feasibility of Economic Evaluation of Diagnostic Procedures. Social Science and Medicine, 1983, 17, 861–869.CrossRefGoogle ScholarPubMed
11.Weisbrod, B. A. Economic Approaches to Evaluating a New Medical Technology: The Drug Cimetidine. In Culyer, A. J. and Horisberger, B., Eds., Economic and Medical Evaluation of Health Care Technologies. Oxford: Oxford University Press, 1981.Google Scholar
12.Williams, A. H.The Cost Benefit Approach. British Medical Bulletin, 1974, 30, 252–256.CrossRefGoogle ScholarPubMed
13.Williams, A. H. The Role of Economics in the Evaluation of Health Care Technologies. In Culyer, A. J. and Horisberger, B., Eds., Economic and Medical Evaluation of Health Care Technologies. Oxford: Oxford University Press, 1981.Google Scholar
14.Williams, A. H.Economics of Coronary Artery Bypass Grafting. British Medical Journal, 1985, 291, 326–329.CrossRefGoogle ScholarPubMed